Results 71 to 80 of about 678 (100)

[Analysis of the new active principles sold in Spain (1992-2002)]. [PDF]

open access: yesAten Primaria, 2005
Baena Díez JM   +5 more
europepmc   +1 more source

Vigabatrin. [PDF]

open access: yesNeurotherapeutics, 2007
Wheless JW, Ramsay RE, Collins SD.
europepmc   +1 more source

[Epilepsy in Patients With Moyamoya Angiopathy]. [PDF]

open access: yesRev Neurol
Bautista-Lacambra M   +9 more
europepmc   +1 more source

Depressogenic effects of medications: a review. [PDF]

open access: yesDialogues Clin Neurosci, 2011
Celano CM   +5 more
europepmc   +1 more source

Pharmacological interventions for epilepsy in people with intellectual disabilities. [PDF]

open access: yesCochrane Database Syst Rev, 2015
Jackson CF, Makin SM, Marson AG, Kerr M.
europepmc   +1 more source

[Abusive Head Trauma in Infants: A Case Review (2016-Present) and Prevention Strategies]. [PDF]

open access: yesRev Neurol
Pérez Delgado R   +5 more
europepmc   +1 more source

Síntesis de análogos de GABA conformacionalmente restringidos. [PDF]

open access: yes
El ácido γ-aminobutírico (GABA) es el principal neurotransmisor inhibitorio del sistema nervioso central (SNC), por lo que desempeña un papel fundamental en la modulación de la excitabilidad neuronal.
JAVIER ULISES SANCHEZ MORALES
core  

[Our Experience with Pediatric Patients Withdrawn from Pharmacological Treatment for Epilepsy who Remain Untreated]. [PDF]

open access: yesRev Neurol
López Pisón J   +5 more
europepmc   +1 more source

[A multicentre epilepsy registry in Mexico]. [PDF]

open access: yesRev Neurol
Reséndiz-Aparicio JC   +2 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy